FilingSEC EDGAR10-Q
enGene Therapeutics Reports Quarterly Results and Announces 50% Workforce Reduction
· SEC accepted
StagePre-commercial
Filing content
enGene Therapeutics reported its quarterly results for the period ended July 31, 2026, and announced a plan to reduce its workforce by approximately 50% to streamline operations and preserve cash.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…